Amar Remedies Peer Comparison
NSE: AMAR | BSE: 532664
₹6.07
As on 11-Dec-2013IST
Market cap
₹16 Cr
Revenue (TTM)
₹492 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
16 | 16,737 | 16,561 | 7,616 | 6,242 |
Revenue (₹ Cr) |
492 | 4,537 | 3,915 | 2,966 | 1,240 |
Net Profit (₹ Cr) |
-42.43 | 188.20 | 753.50 | 284.04 | 223.00 |
Net Margin (%) |
-8.63 | 4.14 | 18.85 | 9.37 | 17.60 |
RoE (%) |
-- | 3.99 | 25.89 | 18.77 | 31.86 |
Price to Earnings |
-- | 88.93 | 22.13 | 26.81 | 27.99 |
Price-To-Book |
0.07 | 2.82 | 5.40 | 4.66 | 7.57 |
Income Statement (₹ Cr)
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Operating Revenue
|
684.37 | 336.75 | 1,453.51 | 913.29 | 473.31 |
|
Total Income
|
686.45 | 345.76 | 1,507.63 | 935.74 | 510.69 |
|
Total Expenditure
|
571.23 | 259.51 | 1,072.60 | 828.91 | 356.80 |
|
EBITDA
|
113.14 | 77.24 | 380.91 | 84.38 | 116.52 |
|
Depreciation
|
12.82 | 3.86 | 120.89 | 24.65 | 2.60 |
|
EBIT
|
100.32 | 73.38 | 260.03 | 59.73 | 113.92 |
|
Interest
|
39.76 | 0.15 | 15.21 | 23.83 | 0.08 |
|
Other Income
|
2.08 | 9.01 | 54.12 | 22.44 | 37.38 |
|
Exceptional Items
|
-5.03 | -- | -- | -- | -18.96 |
|
Profit before Tax
|
57.60 | 82.24 | 298.94 | 58.34 | 151.21 |
|
Provision for Tax
|
12.11 | 13.65 | 40.12 | 19.93 | 31.14 |
|
Profit after Tax
|
45.49 | 68.59 | 258.81 | 38.41 | 120.08 |
Liabilities (₹ Cr)
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
263.47 | 186.86 | 706.63 | 612.42 | 427.84 |
|
Minority Interest
|
-- | 0.93 | 0.12 | 6.69 | -- |
|
Non-Current Liabilities
|
64.65 | 5.33 | 78.65 | 465.06 | 0.96 |
|
Current Liabilities
|
358.10 | 74.24 | 496.10 | 335.17 | 65.26 |
|
Total Liabilities
|
686.22 | 267.36 | 1,281.50 | 1,419.34 | 494.07 |
Assets (₹ Cr)
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
193.96 | 100.74 | 519.31 | 1,090.50 | 82.78 |
|
Current Assets
|
490.40 | 166.62 | 762.19 | 328.84 | 411.28 |
|
Total Assets
|
686.22 | 267.36 | 1,281.50 | 1,419.34 | 494.07 |
|
Total Debt*
|
379.48 | 0.00 | 155.81 | 566.89 | 0.00 |
|
Net Current Assets
|
132.30 | 92.38 | 266.08 | -6.33 | 346.02 |
|
Contingent Liabilities
|
1.56 | 4.61 | 14.70 | 54.62 | -- |
Cashflow (₹ Cr)
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-31.25 | 62.01 | 360.45 | 124.58 | 89.62 |
|
Cash Flow from Investing Activities
|
-48.85 | -2.00 | -132.65 | -615.12 | -42.24 |
|
Cash from Financing Activities
|
76.85 | -18.29 | -144.93 | 413.23 | -101.25 |
|
Net Cash Inflow / Outflow
|
-3.25 | 41.72 | 82.87 | -77.32 | -53.87 |
Ratios
Profitability Ratios
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
ROCE (%)
|
17.64 | 50.12 | 35.37 | 8.74 | 35.36 |
|
ROE (%)
|
19.16 | 41.73 | 37.07 | 6.18 | 28.07 |
|
ROA (%)
|
7.72 | 28.20 | 20.95 | 3.41 | 24.30 |
|
EBIT Margin (%)
|
16.84 | 25.61 | 29.93 | 11.70 | 32.51 |
|
Net Margin (%)
|
6.63 | 19.84 | 17.17 | 4.10 | 23.51 |
|
Cash Profit Margin (%)
|
8.46 | 20.95 | 25.69 | 6.65 | 25.92 |
Growth Ratios
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
14.64 | 0.11 | 16.55 | 45.80 | 0.00 |
|
EBIT Growth (%)
|
36.50 | -5.85 | 8.64 | 10.87 | 22.84 |
|
Net Profit Growth (%)
|
16.20 | 15.32 | 13.16 | -41.57 | 0.00 |
|
EPS Growth (%)
|
16.20 | 13.79 | 13.17 | -35.16 | 0.00 |
|
Book Value Growth (%)
|
21.63 | 31.69 | 2.43 | -2.96 | 0.00 |
Valuation Ratios
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Price / Earnings
|
7.76 | 21.96 | 7.86 | 7.28 | 14.21 |
|
Price / Book Value
|
1.35 | 7.95 | 8.63 | 2.12 | 3.99 |
|
Dividend Yield (%)
|
0.00 | 1.31 | 1.98 | 1.55 | 3.46 |
|
EV/EBITDA
|
6.28 | 15.70 | 13.75 | 16.84 | 10.91 |
|
Market Cap (₹ Cr)
|
352.82 | 1,486.04 | 6,100.90 | 1,298.61 | 1,706.57 |
Solvency Ratios
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.46 | 0.00 | 0.22 | 0.93 | 0.00 |
|
Short term debt to equity ratio
|
1.19 | -- | 0.08 | 0.20 | -- |
|
Current Ratio
|
1.37 | 2.24 | 1.54 | 0.98 | 6.30 |
|
Quick Ratio
|
0.72 | 1.88 | 1.31 | 0.62 | 5.35 |
|
Interest Coverage
|
2.45 | 549.27 | 20.65 | 3.45 | 1,927.30 |
Operating Efficiency Ratios
| Amar Remedies | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
27.44 | 0.21 | 6.92 | 8.84 | 1.09 |
|
Asset Turnover
|
1.17 | 1.42 | 1.20 | 0.84 | 0.96 |
|
Receivable days
|
87.51 | 0.99 | 25.84 | 35.83 | 3.96 |
|
Inventory Days
|
102.13 | 27.32 | 29.09 | 36.85 | 47.77 |
|
Payable days
|
10.84 | 158.46 | 57.04 | 71.26 | 123.25 |
|
Cash Conversion Cycle
|
178.80 | -130.14 | -2.11 | 1.42 | -71.52 |